© 2018 by ICD Pharma. 

Coming soon:

The only product

available for twice-daily

high-dose protocols

300-600 mg pure CBD per capsule

Enhanced bioavailability

High dose CBD was clinically tested for Schizophrenia, Parkinson's, Autism, Epilepsy, and more.

» 

» 

» 

High Dose CBD Capsules

Related Articles

Schizophrenia

Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia

Published:  20 March 2012

Read More

Opiate addiction withdrawal syndrome

Early Phase in the Development of Cannabidiol as a Treatment for Addiction: Opioid Relapse Takes Initial Center Stage.

Published: 12 October 2015

Read More

Epilepsy

Cannabidiol in patients with treatment-resistant epilepsy:

an open-label interventional trial

Published: March 2016

Read More 

Alzheimer’s Disease

In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's Disease

Published: 03 February 2013

Read More

Parkinson’s Disease

Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial

Published: 18 September 2014

Read More